Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-24-037646
Filing Date
2024-12-16
Accepted
2024-12-16 17:18:36
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 rvph20241215_424b5.htm 424B5 621446
2 img01.jpg GRAPHIC 856
3 rvph01.jpg GRAPHIC 8960
  Complete submission text file 0001437749-24-037646.txt   636348
Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-262348 | Film No.: 241552827
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)